Evidence map›Paper›PMID 34015820›Full record

ArticleBriefings in bioinformatics2021

Benchmarking association analyses of continuous exposures with RNA-seq in observational studies.

Tamar Sofer, Nuzulul Kurniansyah, François Aguet, Kristin Ardlie, Peter Durda, Deborah A Nickerson, Joshua D Smith, Yongmei Liu, Sina A Gharib, Susan Redline and 3 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Briefings in bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Tamar SoferProgram of Sleep Medicine Epidemiology at the Brigham and Women's Hospital, USA.
Nuzulul KurniansyahProgram of Sleep Medicine Epidemiology at the Brigham and Women's Hospital, USA.
François AguetBroad Institute of MIT and Harvard, USA.
Kristin ArdlieBroad Institute of MIT and Harvard, USA.
Peter DurdaDepartment of Pathology & Laboratory Medicine at the University of Vermont, USA.
Deborah A NickersonGenome Sciences and the Principal Investigator of the Human Genetics and Translational Genomics program at the University of Washington, USA.
Joshua D SmithHuman Genetics and Translational Genomics program at the University of Washington, USA.
Yongmei LiuDuke Molecular Physiology Institute, USA.
Sina A GharibComputational Medicine Core at the Center of Lung Biology at the University of Washington, USA.
Susan RedlineHarvard School of Medicine and the director of the program in Sleep Medicine Epidemiology at Brigham and Women's Hospital, USA.
Stephen S RichCenter for Public Health Genomics at the University of Virginia, USA.
Jerome I RotterInstitute for Translational Genomics and Population Sciences at the Harbor-UCLA Medical Center at the Lundquist Institute, USA.
Kent D TaylorHarbor-UCLA Medical Center at the Lundquist Institute, USA.
Brigham and Women's Hospital · USUniversity of Washington · USBroad Institute · USHarbor–UCLA Medical Center · USOffice of Public Health Genomics · USUniversity of Vermont · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Phenotypic and Molecular Signatures for Sleep Apnea and Related MorbiditiesR35HL135818 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI REDLINE, SUSAN S. · 2017 to 2023
$7.2M
National Heart, Lung and Blood Institute 75N92020D00001NCATS NIH HHS UL1 TR001420NCATS NIH HHS UL1 TR001881NHLBI NIH HHS R35 HL135818NIDDK NIH HHS P30 DK063491
6 · The paper itself

Abstract

Large datasets of hundreds to thousands of individuals measuring RNA-seq in observational studies are becoming available. Many popular software packages for analysis of RNA-seq data were constructed to study differences in expression signatures in an experimental design with well-defined conditions (exposures). In contrast, observational studies may have varying levels of confounding transcript-exposure associations; further, exposure measures may vary from discrete (exposed, yes/no) to continuous (levels of exposure), with non-normal distributions of exposure. We compare popular software for gene expression-DESeq2, edgeR and limma-as well as linear regression-based analyses for studying the association of continuous exposures with RNA-seq. We developed a computation pipeline that includes transformation, filtering and generation of empirical null distribution of association P-values, and we apply the pipeline to compute empirical P-values with multiple testing correction. We employ a resampling approach that allows for assessment of false positive detection across methods, power comparison and the computation of quantile empirical P-values. The results suggest that linear regression methods are substantially faster with better control of false detections than other methods, even with the resampling method to compute empirical P-values. We provide the proposed pipeline with fast algorithms in an R package Olivia, and implemented it to study the associations of measures of sleep disordered breathing with RNA-seq in peripheral blood mononuclear cells in participants from the Multi-Ethnic Study of Atherosclerosis.

Indexed as

RNA-SeqSequence Analysis, RNASoftwareAlgorithmsAtherosclerosisBenchmarkingComputer SimulationDisease SusceptibilityGenetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingHumansMutationPhenotypeRisk AssessmentRisk FactorsWeb Browsercontinuous exposureempirical P-valuesnon-normalityobservational studiesRNA-seq

Identifiers

PMID34015820
PMCPMC8574950
OpenAlexW3161749941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.